CWM
MRNA icon

Circle Wealth Management’s Moderna MRNA Stock Holding History

Circle Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,090
Closed -$1.47M – 201
2023
Q2 		$1.47M Sell
12,090
-724
-6% -$96.6K 0.19% 42
2023
Q1 		$1.97M Buy
12,814
+146
+1% +$24.1K 0.28% 37
2022
Q4 		$2.28M Sell
12,668
-19
-0.1% -$3.11K 0.35% 33
2022
Q3 		$1.5M Sell
12,687
-77
-0.6% -$11.7K 0.25% 41
2022
Q2 		$1.82M Buy
12,764
+183
+1% +$26.2K 0.29% 39
2022
Q1 		$2.17M Buy
12,581
+527
+4% +$88.7K 0.28% 42
2021
Q4 		$3.06M Buy
12,054
+1,991
+20% +$582K 0.4% 31
2021
Q3 		$3.87M Sell
10,063
-1,997
-17% -$737K 0.56% 26
2021
Q2 		$2.83M Buy
12,060
+12
+0.1% +$2.15K 0.41% 30
2021
Q1 		$1.58M Buy
+12,048
New +$1.75M 0.25% 45

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Circle Wealth Management's MRNA Position: Q3 2023 in Review

Circle Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 12,090 shares — an estimated $1.47M sold.

Circle Wealth Management first reported a position in MRNA in Q1 2021 and held it in 10 quarters. The position peaked at $3.87M in Q3 2021. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Circle Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Circle Wealth Management sold 12,090 Moderna shares in Q3 2023, an estimated $1.47M.
  • Circle Wealth Management first reported a position in Moderna in Q1 2021 and held it in 10 quarters.
  • Circle Wealth Management's Moderna position peaked at $3.87M in Q3 2021.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Circle Wealth Management's 13F filing for Q3 2023, filed 15 Nov 2023.